recall
saveNostrum Laboratories, Inc. recall (Cls II)
August 6, 2025updated 5mo ago
community read0 votes
Sucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003-01, and b) 500-count bottles, NDC 29033-0003-05), Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120. — Reason: CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated. — Status: Ongoing
view source ↗Data sources
last refreshed 36m ago
Found something off?
comments(0)
5-min edit window · permanent after that